Annual CFF
$100.97 M
+$100.92 M+183483.64%
31 December 2023
Summary:
Jasper Therapeutics annual cash flow from financing activities is currently $100.97 million, with the most recent change of +$100.92 million (+183483.64%) on 31 December 2023. During the last 3 years, it has risen by +$89.68 million (+794.58%). JSPR annual CFF is now at all-time high.JSPR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$9000.00
-$172.00 K-95.03%
30 September 2024
Summary:
Jasper Therapeutics quarterly cash flow from financing activities is currently $9000.00, with the most recent change of -$172.00 thousand (-95.03%) on 30 September 2024. Over the past year, it has dropped by -$27.00 thousand (-75.00%). JSPR quarterly CFF is now -99.99% below its all-time high of $101.51 million, reached on 31 March 2023.JSPR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$47.27 M
-$27.00 K-0.06%
30 September 2024
Summary:
Jasper Therapeutics TTM cash flow from financing activities is currently $47.27 million, with the most recent change of -$27.00 thousand (-0.06%) on 30 September 2024. Over the past year, it has dropped by -$54.00 million (-53.32%). JSPR TTM CFF is now -53.60% below its all-time high of $101.88 million, reached on 30 September 2021.JSPR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JSPR Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -75.0% | -53.3% |
| 3 y3 years | +794.6% | -100.0% | -53.6% |
| 5 y5 years | - | - | - |
JSPR Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -100.0% | +101.0% | -53.6% | +5459.2% |
| 5 y | 5 years | at high | >+9999.0% | -100.0% | +101.0% | -53.6% | +5459.2% |
| alltime | all time | at high | >+9999.0% | -100.0% | +101.0% | -53.6% | +5459.2% |
Jasper Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9000.00(-95.0%) | $47.27 M(-0.1%) |
| June 2024 | - | $181.00 K(-99.6%) | $47.30 M(+1.0%) |
| Mar 2024 | - | $47.35 M(<-9900.0%) | $46.81 M(-53.6%) |
| Dec 2023 | $100.97 M(>+9900.0%) | -$271.00 K(-852.8%) | $100.97 M(-0.3%) |
| Sept 2023 | - | $36.00 K(-111.8%) | $101.27 M(+0.0%) |
| June 2023 | - | -$305.00 K(-100.3%) | $101.23 M(-0.3%) |
| Mar 2023 | - | $101.51 M(>+9900.0%) | $101.55 M(>+9900.0%) |
| Dec 2022 | $55.00 K | $28.00 K(+2700.0%) | $55.00 K(-106.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $1000.00(-92.3%) | -$882.00 K(-101.0%) |
| June 2022 | - | $13.00 K(0.0%) | $90.84 M(+0.7%) |
| Mar 2022 | - | $13.00 K(-101.4%) | $90.23 M(-10.6%) |
| Dec 2021 | $100.97 M(+794.6%) | -$909.00 K(-101.0%) | $100.97 M(-0.9%) |
| Sept 2021 | - | $91.73 M(<-9900.0%) | $101.88 M(+903.5%) |
| June 2021 | - | -$600.00 K(-105.6%) | $10.15 M(-5.6%) |
| Mar 2021 | - | $10.75 M | $10.75 M |
| Dec 2020 | $11.29 M | - | - |
FAQ
- What is Jasper Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Jasper Therapeutics?
- What is Jasper Therapeutics annual CFF year-on-year change?
- What is Jasper Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly CFF year-on-year change?
- What is Jasper Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Jasper Therapeutics?
- What is Jasper Therapeutics TTM CFF year-on-year change?
What is Jasper Therapeutics annual cash flow from financing activities?
The current annual CFF of JSPR is $100.97 M
What is the all time high annual CFF for Jasper Therapeutics?
Jasper Therapeutics all-time high annual cash flow from financing activities is $100.97 M
What is Jasper Therapeutics annual CFF year-on-year change?
Over the past year, JSPR annual cash flow from financing activities has changed by +$100.92 M (+183483.64%)
What is Jasper Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of JSPR is $9000.00
What is the all time high quarterly CFF for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly cash flow from financing activities is $101.51 M
What is Jasper Therapeutics quarterly CFF year-on-year change?
Over the past year, JSPR quarterly cash flow from financing activities has changed by -$27.00 K (-75.00%)
What is Jasper Therapeutics TTM cash flow from financing activities?
The current TTM CFF of JSPR is $47.27 M
What is the all time high TTM CFF for Jasper Therapeutics?
Jasper Therapeutics all-time high TTM cash flow from financing activities is $101.88 M
What is Jasper Therapeutics TTM CFF year-on-year change?
Over the past year, JSPR TTM cash flow from financing activities has changed by -$54.00 M (-53.32%)